Litcius/Paper detail

A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations

Huanlan Sa, Yan Shi, Chunxia Ding, Kewei Ma

2023Journal of Cancer Research and Clinical Oncology20 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineLung cancerHematologyEpidermal growth factor receptorAdverse effectOncologyCancerPerformance statusLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Research Studies
A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations | Litcius